跳至主要内容
临床试验/NCT04939181
NCT04939181已完成不适用

Efficacy of Non-invasive Neuromodulation NESA in Neuroefficiency in Basketball Players on the Field

University of Las Palmas de Gran Canaria2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2021年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Changes in creatinine kinase level

研究概览

简要总结

Competitive team sports calendars are becoming increasingly compressed, generating changes in the effort-recovery cycle. Given this new situation, it seems necessary to analyze how it affects the physiological and performance level of semi-professional players, as well as how to observe if the non-invasive neuromodulation technique NESA helps the neuroefficiency and concentration values of said players.

详细描述

The design of this study is a randomised, triple blind clinical trial with placebo control.

The general configuration of the study consists of capturing the second basketball team of FC BARCELONA. For this, a double-blind capture system will be available (neither the specialist nor those responsible for recovery will know which patients are entering the complementary treatment) and two NESA XSIGNAL® devices operating in double-blind (due to the imperceptivity of the stimulation performed, there will be a placebo machine and another that applies the treatment).

At the end of the study, the results obtained between the different groups of patients will be able to be compared; those additionally treated with a device, those treated with a placebo device and those in the standard rehabilitation procedure without a device.

The variables of the study will be collected at three time points: before the intervention, during the intervention and at the end of the intervention.

The statistical analysis will be an intention-to-treat analysis. For the main outcomes variables a two factor ANOVA will-be performed (intervention-time) with a post-hoc analysis with kruskal wallis correction correction. Statistical significance will be defined as p <0.05

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Belonging to the team
  • Participants do not present injury or pathology during the study
  • In normal conditions and mentally competent to participate in the study.
  • In condition to complete the study questionnaires.

排除标准

  • Present some of the contraindications for a treatment with non-invasive neuromodulation: pacemakers, internal bleeding, do not apply electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.
  • Not having signed the informed consent.
  • Present any injury or pathology during the study

结局指标

主要结局

Changes in creatinine kinase level

时间窗: 48 hours before the first match, immediately after the match and 48 hours after the match

For the analysis of these biomarkers, a saliva sample, collected with Salivette containers will be necessary. Once the sample is obtained, it will be kept following the necessary security protocols and sent to a laboratory for further analysis.

次要结局

  • Cardiovascular parameters: heart rate variability (VHR)(Up to 6 weeks)
  • Kinematic demand parameters (external load) II(During the match and all the intervention ( 6 weeks))
  • Perceptual parameters(Up to 6 weeks)
  • Kinematic demand parameters (external load) I(Through study completion, an average of 6 weeks)
  • Kinematic demand parameters (external load) IV(Through study completion, an average of 6 weeks)
  • Kinematic demand parameters (external load) III(During all the intervention ( 6 weeks))
  • Perceptual parameters II(During all the intervention. Up to 6 weeks)

研究者

发起方
University of Las Palmas de Gran Canaria
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aníbal Báez Suárez

Principal Investigator

University of Las Palmas de Gran Canaria

研究点 (2)

Loading locations...

相似试验

Non-invasive Neuromodulation NESA in Neuroefficiency... | 临床试验